Incretins Update: A Holistic Approach to Patients With Type 2 Diabetes and Cardiometabolic Comorbidities

Medical Minute 2: Multisystemic Actions of GIP/GLP-1 Coagonists
Download All
In this series of concise Medical Minute videos and ClinicalThought™ commentaries, expert faculty review the actions and clinical applications of current and emerging incretin-based therapies for persons with type 2 diabetes.
Carol Hatch Wysham, MD

Multisystem Actions of GIP/GLP-1 Coagonists

In this concise Medical Minute video, review the role of the gut in glucose homeostasis and gain expert insight on how GIP/GLP-1 coagonists may harness multisystemic activity to improve outcomes in persons with T2D.

Carol Hatch Wysham, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Registered Dietitians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s) Released: August 18, 2021 Expired: August 17, 2022

In this concise Medical Minute video, review the role of the gut in glucose homeostasis and gain expert insight on how GIP/GLP-1 coagonists may harness multisystemic activity to improve outcomes in persons with T2D.

Carol Hatch Wysham, MD Released: August 18, 2021

When managing patients with type 2 diabetes, we must understand the complex contribution of obesity and the importance of approaching weight loss for treatment.

Carol Hatch Wysham, MD Released: September 2, 2021
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue